ALNOV.PA
Novacyt SA
Price:  
0.55 
EUR
Volume:  
37,586.00
France | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ALNOV.PA EV/EBITDA

-713.6%
Upside

As of 2025-03-22, the EV/EBITDA ratio of Novacyt SA (ALNOV.PA) is -0.73. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALNOV.PA's latest enterprise value is 18.84 mil EUR. ALNOV.PA's TTM EBITDA according to its financial statements is -25.95 mil EUR. Dividing these 2 quantities gives us the above ALNOV.PA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 7.8x - 9.0x 8.8x
Forward P/E multiples 9.7x - 13.5x 11.0x
Fair Price (3.28) - (3.03) (3.36)
Upside -698.9% - -654.5% -713.6%
0.55 EUR
Stock Price
(3.36) EUR
Fair Price

ALNOV.PA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-03-06 -0.82
2025-03-05 -0.82
2025-03-04 -0.80
2025-03-03 -0.87
2025-02-28 -0.86
2025-02-27 -0.88
2025-02-26 -0.87
2025-02-25 -0.87
2025-02-24 -0.94
2025-02-21 -0.83
2025-02-20 -0.86
2025-02-19 -0.82
2025-02-18 -0.86
2025-02-17 -0.88
2025-02-14 -0.85
2025-02-13 -0.89
2025-02-12 -0.86
2025-02-11 -0.86
2025-02-10 -0.85
2025-02-07 -0.88
2025-02-06 -0.90
2025-02-05 -0.94
2025-02-04 -0.92
2025-02-03 -0.94
2025-01-31 -0.97
2025-01-30 -0.99
2025-01-29 -0.92
2025-01-28 -0.91
2025-01-27 -1.01
2025-01-24 -0.89
2025-01-23 -0.86
2025-01-22 -0.90
2025-01-21 -0.89
2025-01-20 -1.03
2025-01-17 -1.05
2025-01-16 -1.16
2025-01-15 -1.11
2025-01-14 -1.08
2025-01-13 -1.10
2025-01-10 -1.20
2025-01-09 -1.23
2025-01-08 -1.19
2025-01-07 -1.25
2025-01-06 -1.10
2025-01-03 -1.06
2025-01-02 -0.88
2024-12-31 -0.88
2024-12-30 -0.83
2024-12-27 -0.88
2024-12-24 -0.84